menu toggle
COVID-19 : 리소스 센터 (자료 센터)
COVID-19에 대한 World Courier의 운영 업데이트 및 포괄적인 정보를 확인하십시오.

Manufacturer Solutions

Creating sustainability & longevity for Biosimilars


At AmerisourceBergen, we believe in the promise of biosimilars to deliver cost savings across healthcare. We also understand the potential hurdles these unique products will face. That's why we offer solutions for increasing access to and confidence in these emerging therapies.

For manufacturers

Distribution & commercialization services

Our experts can help you devise channel strategies and tailored solutions for access and uptake. And, we have market-leading reach into the sites of care where patients are being treated with biosimilars.

For providers

Education, solutions & support

Our market-leading GPOs connect physicians and manufacturers for unrivaled purchasing power and education while our provider solutions offer tailored services for all sites of care. Plus, field reimbursement support helps practices navigate payment for these new products.

For patients

Impacting access, affordability & adherence

Our patient assistance program (PAP) models and adherence services are tailored to your product and patient needs and integrate seamlessly with our reimbursement and co-pay services.

Our relationships span:



of U.S. hospitals and health systems



of U.S. community oncology market



of U.S. renal market



provider sites



provider sites

  A guide for understanding the growing market

Biosimilar Pipeline Report

This reference guide is a useful tool to visualize and understand the current product landscape and potential future of this emerging market. 

We advance access with integrated commercialization services for all biosimilars

Field reimbursement support
Expand patient access with a customized field reimbursement and access support solution.
GPO access & provider education
Enable healthcare providers to enhance patient care with our services and solutions.
Patient access, affordability, and adherence
Our solutions can help identify potential barriers to access and increase speed to therapy for your patients.
Market access consulting
Our market access experts translate evidence into campaigns that compel, inform, intrigue – and most importantly – drive results.

Resources & education

Read the FDA's guidance on biosimilars and get answers to patients' frequently asked questions.

"The right conditions exist in the U.S. for biosimilar commercialization success. Competition has proven to bring prices down – look at the generics market over the last 30 years – but now we need to create a supportive system."

Steve Collis, Chairman, President and CEO, AmerisourceBergen 

Related Insights

Connect with our team

We are here to support you with innovative solutions to help increase access to these emerging therapies.